The Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Orally Dosed QY201, a Novel JAK1/TYK2 Inhibitor, in Chinese Healthy Subjects.

已完结 20 由追风者发布于 2025/8/25 8:40:08

DOI:10.1002/jcph.70053
作者：Jia-Ying Wang,?Ying-Hui Gao,?Zou-Rong Ruan,?Dan-Dan Yang,?Hua Li,?Shi-da Qiao,?Jian-Hui Li,?Xin You,?Jun Shi,?Bo Jiang
文献类型：期刊论文
补充材料：只需要正文

Wiley

Abstract：QY201 is a dual inhibitor targeting Janus Kinase 1/Tyrosine Kinase 2, developed for the treatment of atopic dermatitis and other autoimmune diseases. The pharmacokinetics (PK), pharmacodynam

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Institute of Electrical and Electronics Engineers (IEEE)Understanding Visual Privacy Protection: A Generalized Framework With an Instance on Facial Privacy